• HOME
  • BUSINESS
Login
Signup
  • News
  • Finance
  • Legal
  • Companies
  • Markets
  • Lifestyle
  • EDUCATION
  • Science
  • Survey
  • Bank fraud: ED attaches assets worth Rs 1,122 cr of Vadodara-based DPIL
  • Govt acts against rape, but make sons more responsible: Modi at rally
  • Congress' decision on impeachment motion was not correct: Mamata
  • GMR, ITC show interest to adopt Taj Mahal, Cement company to adopt Red Fort
25 Apr, 2018 IST
You are here : Home » Companies
Posted On : 14 Nov, 2017  Source : IANS  Place : Hyderabad 
Dr Reddy's launches Clofarabine injection in US market
Dr Reddy's Laboratories

Pharma major Dr Reddy's Laboratories Ltd on Tuesday launched Clofarabine injection, usually prescribed to treat a type of cancer of the white blood cells, in the US market.

Approved by the US Food and Drug Administration (USFDA), it is a therapeutic equivalent generic version of Clolar (clofarabine) injection.

The Clolar brand and generic had US sales of approximately $53 million MAT (Moving Annual Total) for the 12 months ended in September 2017, according to IMS Health, which provides information services for the healthcare industry.

Clofarabine injection is available in single-dose, 20 mL flint vials containing 20 mg of clofarabine in 20 mL of solution (1mg/mL), the Hyderabad-based firm said in a statement.

Clolar is a registered trademark of Genzyme Corporation.

HEAD LINES
  • GMR, ITC show interest to adopt Taj Mahal, Cement company to adopt Red Fort
  • Need for India to do well on human development index: Kant
  • Bank fraud: ED attaches assets worth Rs 1,122 cr of Vadodara-based DPIL
TOP NEWS
  • GMR, ITC show interest to adopt Taj Mahal, Cement company to adopt Red Fort
  • Involvement in India will be investigated: Cambridge Analytica
  • Bharti Airtel's fourth quarter net profit drops 78%
  • HCL, MOIL sign MoU for Malanjkhand copper project
  • Tata Sons appoints ex-foreign secy Jaishankar as global corp affairs head
  • TCS keen to join hands with govt for emergency services to accident victims, organ harvesting: Gadkari
  • TCS first Indian company to achieve $100 billion m-cap
  • Russia bans Google's IP addresses to block Telegram
  • Apple loses $60bn over reports of weak smartphone demand in 2018
  • Canon infusing AI into cameras for Indian millennials
  • Sebi fines Suzlon Energy over Rs 1 cr for violation of SCRA
  • IMA for Electrosteel Steels till Vedanta gets control
  • Gionee to launch new smartphones in India on April 26
  • Motorola opens 25 'Moto Hubs' in North-East
  • SG Estates to invest Rs 250 cr on a housing project at Ghaziabad
  • Japan-based Komori eyes Rs 200 crore business in India
  • Audi India sees flat sales in 2018 following duty hike
  • Google to 'pause investments' in messaging mobile app Allo: Report
  • Panasonic launches new smartphone with 'Big View' Display
  • 'Vivo V9 Youth' with dual rear camera in India
  • LAVA launches first all-women operated service centre in India
  • Dell brings AMD Ryzen processors to its 'Inspiron' series
  • Less data requests from cops: Microsoft
Comments
Please signup or login to comment on current news
  • Canon infusing AI into cameras for Indian millennials

© 2018 | All Rights reserved | The First Mail

  • Privacy Policy
  • Disclaimer
  • Terms Of Use
  • CONTACT US

Powered by : Gigasoft™